This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–6.
McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–28.
Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–5.
Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg. 1989;9:691–6.
Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–34.
Stoyioglou A, Jaff MR. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol. 2004;15:1197–207.
Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischaemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464–71.
Schanzer A, Goodney PP, YouFu L, et al. Validation of the PIII CLI Risk Score for the prediction of amputation-free survival in patients undergoing surgical bypass for critical limb ischaemia. J Vasc Surg. 2009;50:769–75.
Rose SC. Noninvasive vascular laboratory for evaluation of peripheral arterial occlusive disease. Part II. Clinical applications: chronic atherosclerotic, lower extremity ischaemia. J Vasc Interv Radiol. 2000;11:1257–75.
Brewster DC. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg. 1997;25:365–79.
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA. Fowkes FGR on behalf of the TASC II working group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S54–7.
Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. Br J Surg. 2005;92:565–9.
Kim YW, Lee JH, Kim HG, Huh S. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg. 2005;30:376–80.
AbuRahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease. J Vasc Surg. 2001;33:S93–9.
Ricco JB, Probst H. French University Surgeons Association. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg. 2008;47:45–53.
Porter JM, Eidemiller LR, Dotter CT, Rosch J, Vetto RM. Combined arterial dilatation and femorofemoral bypass for limb salvage. Surg Gynecol Obstet. 1973;137:409–12.
Walker PJ, Harris JP, May J. Combined percutaneous transluminal angioplasty and extra-anatomic bypass for symptomatic unilateral iliac occlusion with contralateral iliac artery stenosis. Ann Vasc Surg. 1991;5:209–17.
Shah RM, Peer RM, Upson JF, Ricotta JJ. Donor iliac angioplasty and crossover femorofemoral bypass. Am J Surg. 1992;164:295–8.
Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass. Analysis of 70 consecutive cases with long-term follow-up. J Vasc Surg. 1996;24:363–70.
Schneider JR, Besso SR, Walsh DB, Zwolack RM, Cronenwett JL. Femorofemoral versus aortofemoral bypass. Outcome and hemodynamic results. J Vasc Surg. 1994;19:43–57.
Criado E, Burnham SJ, Tinsley EA, Johnson G, Keagy BA. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome. J Vasc Surg. 1993;18:495–505.
Brewster DC, Cambria RF, Darling RC, et al. Long-term results of combined iliac balloon angioplasty and distal surgical revascularization. Ann Surg. 1989;210:324–31.
Cynamon J, Marin ML, Veith FJ, et al. Stent-graft repair of aortoiliac occlusive disease coexisting with common femoral artery disease. J Vasc Interv Radiol. 1997;8:19–26.
Heart Protection Study Collaborative Group. Randomised trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20, 536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45:645–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ricco, JB., Page, O. (2018). Lower Limb Claudication Due to Bilateral Iliac Artery Occlusive Disease: The Case for Iliac Stenting and Femorofemoral Crossover Bypass. In: Geroulakos, G., Sumpio, B. (eds) Vascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-65936-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-65936-7_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65935-0
Online ISBN: 978-3-319-65936-7
eBook Packages: MedicineMedicine (R0)